E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions
Open Access
- 1 December 2014
- journal article
- research article
- Published by Springer Nature in Journal of the Egyptian National Cancer Institute
- Vol. 26 (4) , 211-217
Abstract
Background: Loss of E-cadherin is a critical step for development and progression of malignant tumors. CD10; a marker of non-neoplastic and neoplastic endometrial stroma, is associated with aggressiveness of many epithelial malignancies. Aims: To evaluate expression and correlation of E-cadherin and CD10 in endometrial lesions and their possible role in differentiating atypical endometrial hyperplasia from endometrial carcinoma. The association of E-cadherin and CD10 expression with clinico-pathological parameters of endometrial carcinoma was also investigated. Materials and methods: Fifty four cases including 28 endometrial carcinomas; 19 endometrial hyperplasia and 7 cases of normal endometrial changes were enrolled for this study. The expression of E-cadherin and CD10 was evaluated by immunohistochemistry using the streptavidin-biotin technique. Results: There was a strong association between malignant change of endometrial glands and mem-brano-cytoplasmic localization of E-cadherin (p < 0.001). Expression of E-cadherin but not CD10 was significantly higher in endometrial carcinomas compared to atypical endometrial hyperplasia (p < 0.01). Expression of E-cadherin was not associated with CD10 expression in different endometrial lesions. High grade tumors expressed low levels of both E-cadherin (p < 0.01) and CD10 (p < 0.05) and serous endometrial carcinoma had low E-cadherin and CD10 expression compared to endometrioid carcinoma (p < 0.01 and < 0.05, respectively). Expression of both molecules showed no association with depth of tumor invasion or FIGO stage. Tumors with lower E-cadherin or CD10 expression had higher rates of vascular tumor emboli (p < 0.01 and < 0.07, respectively). Conclusions: Although expression of E-cadherin and CD10 in endometrial lesions was not correlated, reduced expression of both molecules could be critical for progression of endometrial carcinoma. (C) 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.Keywords
This publication has 37 references indexed in Scilit:
- Epithelial to mesenchymal transition in cutaneous squamous cell carcinoma is correlated with COX-2 expression but not with the presence of stromal macrophages or CD10-expressing cellsVirchows Archiv, 2012
- Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and CancerStem Cells, 2011
- Stromal CD10 expression and relationship to the E‐cadherin/β‐catenin complex in breast carcinomaHistopathology, 2010
- Adhesion molecules and p16 expression in endocervical adenocarcinomaVirchows Archiv, 2009
- Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotypeJournal of Clinical Pathology, 2007
- CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasisAPMIS, 2007
- Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentBritish Journal of Cancer, 2003
- The Clinical Significance of CD10 Antigen Expression in Diffuse Large B-Cell LymphomaAmerican Journal of Clinical Pathology, 2001
- Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly.Journal of Cell Biology, 1994
- Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor CellsJapanese Journal of Cancer Research, 1989